Atlas Trials

An Open Label, Single-Centre, Pilot Study of Everolimus With EBRT for the Treatment of mNET Liver Metastasis

Clinical trial NCT02205515 · COMPLETED

Trial details

NCT number
NCT02205515
Sponsor
Sunnybrook Health Sciences Centre
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Carcinoma, Neuroendocrine
Start date
2016-03-01
Primary completion
2021-09-01
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.